In vitro chloroquine resistance modulation study on fresh isolates of Brazilian Plasmodium falciparum: Intrinsic antimalarial activity of phenothiazine drugs

Memorias do Instituto Oswaldo Cruz

Volumn 97, Issue 7, 2002, Pages 1033-1039

  Menezes, Carla M S ^a   Kirchgatter, Karin ^b   Di Santi, Sílvia M ^b   Savalli, Carine ^a   Monteiro, Fabiola G ^a   Paula, Gilberto A ^a   Ferreira, Elizabeth I ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SUPERINTENDÊNCIA DE CONTROLE DE ENDEMIAS   (Brazil)

Author keywords

Antimalarial; Chemosensitizer agents; Chloroquine; Modulating agents; Multidrug resistance; Phenothiazines

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; PHENOTHIAZINE DERIVATIVE;

ADULT; ANIMAL; ARTICLE; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HUMAN; MALE; METHODOLOGY; PLASMODIUM FALCIPARUM; STATISTICAL MODEL;

ADULT; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; FEMALE; HUMANS; LINEAR MODELS; MALE; PARASITIC SENSITIVITY TESTS; PHENOTHIAZINES; PLASMODIUM FALCIPARUM;

EID: 0036781427     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762002000700018     Document Type: Article

References (39)

1. Arez AP, Snounou G, Pinho J, Sousa CA, Modiano D, Ribeiro H, Franco AS, Aives J, Rosario VE 1999. A clonal Plasmodium falciparum population in an isolated outbreak of malaria in the Republic of Cabo Verde. Parasitology 118: 347-355.
2. Atamna H, Krugliak M, Shalmiev G, Deharo E, Pescarmona G, Ginsburg H 1996. Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P vinckei petteri and P. yoelii nigeriensis in vivo. Biochem Pharmacol 51: 693-700.
3. Basco LK, Le Bras J 1990. Reversal of chloroquine resistance with desipramine in isolates of Plasmodium falciparum from Central and West Africa. Trans R Soc Trop Med Hyg 84: 479-481.
4. Basco LK, Le Bras J 1992. In vitro activities of chloroquine in combination with chlorpromazine and prochlorperazine against isolates of Plasmodium falciparum. Antimicrob. Ag Chemother 36: 209-213.
5. Basco LK, Ringwald P, Le Bras J 1991. Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro. Ann Trop Med Parasitol 85: 223-228.
6. Benet LZ, Øie S, Schwartz JB 1996. Design and optimization of dosage regimens pharmacokinetic data. In JG Hardman, LE Limbird, PB Molinoff, RW Ruddon. AG Gilmann (eds), Goodman & Gilman's: the Pharmacological Basis of Therapeutics, 9th ed., Pergamon-Press, New York, p. 1707-1792.
7. Bitonti AJ, McCann PP 1989. Desipramine and cyproheptadine for reversal of chloroquine resistance in Plasmodium falciparum. Lancet 2: 1282-1283.
8. Bitonti AJ, Sjoerdsma A, Mccann PP, Kyle DE, Oduola AMJ, Rossan RN, Milhous WK, Davidson Jr DE 1988. Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science 242: 1301-1303.
9. Breslow NE, Day NE 1980. Statistical Methods in Cancer Research. 1. The Analysis of Case Control Studies, International Agency for Research on Cancer, Lyon, 350 pp.
10. Bruce-Chwatt LJ 1986. Chemotherapy of Malaria, 2nd ed., WHO, Geneva, p. 211-233.
11. Clarke EC 1986. Isolation and Identification of Drugs in Pharmaceuticals. Body Fluids and Post-mortem Material, 2nd ed., Pharmaceutical Press, London, 1223 pp.
12. Collett D 1991. Modelling Binary Data, Chapman & Hall, London, 369 pp.
13. Dominguez JN, Lopez S, Charris J, Iarruso L, Lobo G, Semenov A, Olson JE, Rosenthal PJ 1997. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease. J Med Chem 40: 2726-2732.
14. Geary TG, Divo AA, Jensen JB 1986. Effect of calmodulin inhibitors on viability and mitochondrial potential of Plasmodium falciparum in culture. Antimicrob Ag Chemother 30: 785-788.
15. Kristiansen JE, Jepsen S 1985. The susceptibility of Plasmodium falciparum in vitro to chlorpromazine and the stereoisomeric compounds cis(Z)- and trans(E)-clopenthixol. Acta Pathol Microb Immunol Scand (Section B) 93: 249-251.
16. Krogstad DJ, Gluzman IY, Kyle DE, Oduola AMJ, Martin SK, Milhous WK, Schlesinger PH 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238: 1283-1285.
17. Kyle DE, Milhous WK, Rossan RN 1993. Reversal of Plaxmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys. Am J Trop Med Hyg 48: 126-133.
18. Kyle DE, Oduola AMJ, Martin SK, Milhous WK 1990. Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro. Trans R Soc Trop Med Hyg 84: 474-478.
19. 3H-hypoxanthine. Pathol Biol 32: 463-466.
20. Luond RM, McKie JH, Douglas KT, Dascombe MJ, Vale J 1998. Inhibitors of glutathione reductase as potential antimalarial drugs. Kinetic cooperativity and effect of dimethyl sulphoxide on inhibiton kinetics. J Enzyme Inhib 13: 327-345.
21. Martin SK, Oduola AMJ, Milhous WK 1987. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235: 899-901.
22. Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LMB, Jacobs-Lorena V, Mcnamara DT, Bockarie MJ, Kazura JW, Kyle DE, Fidock DA, Zimmerman PA 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in Papua New Guinea and South America. Proc Natl Acad Sci USA 98: 12689-12694.
23. Menezes CMS, Kirchgatter K, Di Santi SMF, Savalli C, Monteiro FG, Paula GA, Ferreira EI 1997. Antimalarial effect in vitro and lack of modulating effect of desipramine and imipramine. Trans R Soc Trop Med Hyg 91: 697-700.
24. Miki A, Tanabe K, Nakayama T, Kiryon C, Ohsawa K 1992. Plasmodium chabaudi: association of reversal of chloroquine resistance with increased accumulation of chloroquine in resistant parasites. Exp Parasitol 74: 134-142.
25. Oduola AMJ, Sowunmi A, Milhous WK, Brewer TG, Kyle DE, Gerena L, Rossan RN, Salako LA, Schuster BG 1998. In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine. Am J Trop Med Hyg 58: 625-629.
26. Padmanaban G, Rangarajan PN 2000. Heme metabolism of Plasmodium is a major antimalarial target. Biochem Biophvs Res Commun 268: 665-668.
27. Panijpan B, Kantakanit N 1983. Chlorpromazine enhances haemolysis induced by haemin. J Pharm Pharmacol 35: 473-475.
28. Peters W, Ekong R, Robinson BL, Warhurst DC, Xing-Qing P 1990. The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents. Ann Trop Med Parasitol 84: 541-551.
29. Philipps J, Radloff PD, Wernsdorfer W, Kremsner PG 1998. Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon. Am J Trop Med Hyg 58: 612-618.
30. Rieckmann KH, Sax LJ, Campbell GH, Mrema JE 1978. Drug sensitivity of Plasmodium falciparum. An in vitro microtechnique. Lancet I: 22-23.
31. Scheibel LW, Colombani PM, Hess AD, Aikawa M, Atkinson CT, Milhous WK 1987. Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design. Proc Nutl Acad Sci USA 84: 7310-7314.
32. Tracy JW, Webster Jr LT 1996. Drugs used in the chemotherapy of protozoa infections: malaria, in JG Hardman, LE Limbird, PB Molinoff, RW Ruddon, AG Gilmann (eds), Goodman & Gilman's. the Pharmacological Basis of Therapeutics. 9th ed., Pergamon-Press, New York, p. 965-985.
33. Trager W, Jensen BB 1976. Human malaria parasites in continuous culture. Science 193: 673-675.
34. Vennerstrom JL, Makler MT, Angerhofer CCK, Williams JA 1995. Antimalarials dyes revisited: xanthenes, azines, oxazines, and thiazines. Antimicrob Ag Chemother 39: 2671-2677.
35. Warsame M, Kilimali AEB, Wernsdorfer WH, Lebbad M, Rutta AS, Ericsson O 1999. Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania. Trans R Soc Trop Mod Hyg 93: 312-313.
36. Ward SA, Bray PG 2001. Is reversal of chloroquine ready for clinic? Lancet 357: 904.
37. Wellems TE, Plowe CV 2001. Chloroquine-resistant malaria. J Infect Dis 184: 770-776.
38. WHO-World Health Organization 2000. Malaria, a Global Crisis. Fact sheet 1. The problem, WHO 03/06/00. Available from: www.rbm.who.int
39. Yang HL, Liu DQ, Yang YM, Huang KG, Dong Y, Yang PF, Liao MZ, Zhang CY 1997. In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas. South Asian J Trop Med Pub Health 28: 460-464.